5 patents
Utility
Ascorbic Acid and Quinone Compound for Cancer Treatment
29 Dec 22
Thomas M. Miller, Zhivko Zhelev
Filed: 13 Jun 22
Utility
Intratumoral Administration of Ascorbic Acid and Quinone Compounds for Tumor Treatment
29 Dec 22
Provided herein is a method of treating or alleviating one or more symptoms of a tumor in a subject, comprising intratumorally administering to the subject a therapeutically effective amount of ascorbic acid and a quinone compound
Thomas M. Miller, Zhivko Zhelev
Filed: 13 Jun 22
Utility
Ascorbic Acid and Quinone Compounds In Combination with an Antiparasitic Agent for Treating a Parasitic Disease
25 Nov 21
Provided herein is a method of treating, preventing, or alleviating one or more symptoms of Chagas disease in a subject, comprising administering to the subject: (i) ascorbic acid, or a single enantiomer, a mixture of enantiomers, or a mixture of diastereomers thereof; or a pharmaceutically acceptable salt, solvate, or hydrate thereof; (ii) a quinone compound, or a single enantiomer, a mixture of enantiomers, or a mixture of diastereomers thereof, or a pharmaceutically acceptable salt, solvate, hydrate, or prodrug thereof; and (iii) an antiparasitic agent.
Sueli de Oliveira Silva Lautenschlager, Vania Cristina Desoti, Celso Vataru Nakamura, Valdecir Farias Ximenes
Filed: 5 Jun 19
Utility
Ascorbic Acid, Quinone Compound, and Sodium Glucose Cotransporter Inhibitor for Treating Cancer
16 Sep 21
Provided herein is a method of treating, preventing, or alleviating one or more symptoms of cancer in a subject, comprising administering to the subject a therapeutically effective amount of: (i) ascorbic acid, or a single enantiomer, a mixture of enantiomers, or a mixture of diastereomers thereof; or a pharmaceutically acceptable salt, solvate, or hydrate thereof; (ii) a quinone compound, or a single enantiomer, a mixture of enantiomers, or a mixture of diastereomers thereof; or a pharmaceutically acceptable salt, solvate, hydrate, or prodrug thereof; and (iii) a sodium glucose cotransporter inhibitor, or a single enantiomer, a mixture of enantiomers, or a mixture of diastereomers thereof; or a pharmaceutically acceptable salt, solvate, hydrate, or prodrug thereof.
Thomas M. Miller, Stephen M. Coutts
Filed: 31 Jul 17
Utility
Ascorbic Acid and Quinone Compounds for Treating Chagas Disease
13 Nov 19
Provided herein is a method of treating, preventing, or alleviating one or more symptoms of Chagas disease in a subject, comprising administering to the subject (i) ascorbic acid, or a single enantiomer, a mixture of enantiomers, or a mixture of diastereomers thereof; or a pharmaceutically acceptable salt, solvate, or hydrate thereof; and (ii) a quinone compound, or a single enantiomer, a mixture of enantiomers, or a mixture of diastereomers thereof, or a pharmaceutically acceptable salt, solvate, hydrate, or prodrug thereof.
Sueli de Oliveira Silva Lautenschlager, VĂ¢nia Cristina Desoti, Celso Vataru Nakamura, Valdecir Farias Ximenes
Filed: 4 Dec 17
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first